| Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064 | Imperial College London | — |
| Not Yet Recruiting | AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2) NCT07260734 | Imperial College London | — |
| Not Yet Recruiting | A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers NCT07233850 | Shenyang Sunshine Pharmaceutical Co., LTD. | Phase 2 |
| Not Yet Recruiting | Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surg NCT07159711 | Guy's and St Thomas' NHS Foundation Trust | — |
| Recruiting | PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer NCT06906887 | Medical College of Wisconsin | Phase 2 |
| Not Yet Recruiting | Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Pa NCT06414122 | University of Cologne | N/A |
| Not Yet Recruiting | Use of Different Enteral Feeds to Impact on Chyle Leaks in Oesophagectomy NCT06965205 | Royal College of Surgeons, Ireland | N/A |
| Recruiting | Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibr NCT06782412 | KU Leuven | Phase 2 / Phase 3 |
| Recruiting | A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers NCT06422403 | National University Hospital, Singapore | Phase 2 |
| Not Yet Recruiting | Post Oesophagectomy Outcomes in a Single Regional Centre in Australia NCT06662513 | Launceston General Hospital | — |
| Recruiting | Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study NCT06364553 | Erasmus Medical Center | N/A |
| Recruiting | Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients with Oesophageal Cancer (VALUE) NCT06440174 | University Hospital Southampton NHS Foundation Trust | — |
| Completed | Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery NCT06277921 | P. Herzen Moscow Oncology Research Institute | — |
| Recruiting | PRIORITY-CONNECT 2 Pilot Trial NCT06212700 | Surgical Outcomes Research Centre (SOuRCe) | N/A |
| Recruiting | Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms NCT06169163 | Imperial College London | — |
| Unknown | Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer NCT06046846 | Queen Margaret University | N/A |
| Recruiting | REVOLUTION Surgery (REVOLUTION Surgery) NCT05642819 | University of Edinburgh | — |
| Completed | A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors NCT05784597 | Philogen S.p.A. | Phase 1 |
| Recruiting | The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study NCT05804331 | Western Sydney Local Health District | — |
| Unknown | Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Col NCT05831488 | Royal Marsden NHS Foundation Trust | — |
| Recruiting | PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer NCT04564482 | Johannes Laengle, MD, PhD | N/A |
| Recruiting | PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC210 NCT05357846 | Sun Yat-sen University | Phase 3 |
| Unknown | Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome NCT05600608 | Anuja Mitra | N/A |
| Unknown | Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastri NCT05685862 | Frisius Medisch Centrum | — |
| Completed | Google Location History Following Oesophagectomy and/or Gastrectomy NCT05035602 | Imperial College London | — |
| Active Not Recruiting | Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors NCT06302660 | Imperial College London | — |
| Recruiting | Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) NCT05412758 | Imperial College London | N/A |
| Unknown | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer NCT03958019 | University of Dublin, Trinity College | N/A |
| Suspended | Upper GI Serial Tumour Biopsies NCT05233007 | The Christie NHS Foundation Trust | — |
| Recruiting | A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzu NCT05143970 | Institut Paoli-Calmettes | Phase 1 |
| Active Not Recruiting | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours NCT05057013 | Cancer Research UK | Phase 1 / Phase 2 |
| Recruiting | Anorexia iN Cancer Patients: ANCHOR NCT04791254 | The Christie NHS Foundation Trust | — |
| Unknown | Unintentional Weight Loss After Oesophagectomy NCT05074914 | University College Dublin | N/A |
| Completed | ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivo NCT04603339 | University of Dublin, Trinity College | N/A |
| Terminated | Esophageal Multisegmented FCSEMS for Malignant Strictures NCT04415463 | Radboud University Medical Center | N/A |
| Completed | EndoVE endosCopic Treatment for Oesophageal and Gastric canceR NCT04649372 | Mirai Medical | N/A |
| Recruiting | TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY NCT04481256 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Completed | PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) NCT04484636 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | N/A |
| Terminated | The PLATON Network NCT05489250 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | — |
| Terminated | Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy NCT04517448 | Centre Hospitalier de la côte Basque | — |
| Unknown | Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURC NCT04232735 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Completed | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. NCT05266300 | University of Southern Denmark | — |
| Unknown | Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Tr NCT04440800 | Royal Marsden NHS Foundation Trust | — |
| Completed | Nutrition in Gastrointestinal Tumors NCT04476082 | University Medicine Greifswald | — |
| Terminated | Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis NCT04508140 | Highlight Therapeutics | Phase 2 |
| Completed | Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention o NCT04237090 | Ciusss de L'Est de l'Île de Montréal | Phase 3 |
| Unknown | Non-invasive Testing for Early oEesophageal Cancer and Dysplasia NCT04001478 | Imperial College London | — |
| Unknown | A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer NCT03829345 | Royal Marsden NHS Foundation Trust | Phase 2 |
| Completed | Gastrointestinal Functional Outcome Ivor Lewis NCT03658837 | University Hospitals, Leicester | — |
| Active Not Recruiting | Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab NCT03653052 | Simon C Pacey, MD | Phase 2 |
| Recruiting | Cardiopulmonary Toxicity of Thoracic Radiotherapy NCT03978377 | University Medical Center Groningen | — |
| Unknown | The Bacterial Composition of the Stomach in Reflux Disease NCT03835663 | Imperial College London | — |
| Completed | Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer NCT03529669 | University of Oxford | N/A |
| Completed | A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly P NCT03416244 | AIO-Studien-gGmbH | Phase 2 |
| Completed | BT1718 in Patients with Advanced Solid Tumours. NCT03486730 | Cancer Research UK | Phase 1 / Phase 2 |
| Completed | Effects of Increased Physical Activity Before Thoracoabdominal Esophageal Surgery NCT03452319 | Göteborg University | N/A |
| Completed | Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Un NCT04440124 | University Hospital Birmingham NHS Foundation Trust | — |
| Completed | The Association Between Preoperative CPEX and Postoperative Morbidity Following Oesophagectomy NCT03216694 | University of East Anglia | — |
| Completed | A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer NCT03212469 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 1 / Phase 2 |
| Unknown | Swedish Oesophago-Gastric Study NCT05540119 | Karolinska Institutet | — |
| Unknown | Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Con NCT02780921 | University Hospital, Clermont-Ferrand | Phase 3 |
| Unknown | Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation NCT02741856 | Lisette Nixon | Phase 2 / Phase 3 |
| Terminated | Physical Activity Intervention Trial to Mitigate Muscle Loss and Increase Muscle Strength NCT02774551 | Karolinska Institutet | N/A |
| Terminated | A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer NCT02489201 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Phase 1 / Phase 2 |
| Unknown | Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCR NCT02465736 | Sun Yat-sen University | Phase 3 |
| Terminated | NY-ESO-1 T Cells in OG Cancer NCT01795976 | Fiona Thistlethwaite | Phase 2 |
| Completed | Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esopha NCT02526134 | Institut Paoli-Calmettes | Phase 2 |
| Completed | The Hemodynamic Effect Between Two Types of Anesthesia in Esophageal Surgery NCT03185403 | University Hospital, Lille | N/A |
| Unknown | A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer NCT01843829 | Lisette Nixon | Phase 2 |
| Completed | Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition NCT02382237 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Completed | ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study NCT01915693 | Lisette Nixon | Phase 3 |
| Completed | NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-A NCT01726452 | Cancer Trials Ireland | Phase 3 |
| Unknown | Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours NCT01795768 | Royal Marsden NHS Foundation Trust | Phase 2 |
| Terminated | The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis Esophagectomy NCT01361750 | Peking University | N/A |
| Unknown | Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinom NCT00934505 | Centre Henri Becquerel | — |
| Completed | Quality of Life After Oesophageal or Gastric Cancer Surgery NCT01657175 | Region Skane | N/A |
| Completed | Role of Radiotherapy Following Oesophageal Stenting in Cancer NCT01179074 | All India Institute of Medical Sciences | N/A |
| Completed | Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in NCT00359645 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 |
| Unknown | Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients W NCT00220077 | Royal Marsden NHS Foundation Trust | N/A |
| Unknown | Swedish Esophageal and Cardia Cancer Study NCT06031155 | Karolinska Institutet | — |